These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 2416868)
21. Antiproliferative response of human leukemic cells: lectin induced inhibition of DNA synthesis and cellular metabolism. Borrebaeck CA; Schön A Cancer Res; 1987 Aug; 47(16):4345-50. PubMed ID: 3607766 [TBL] [Abstract][Full Text] [Related]
22. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1). Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094 [TBL] [Abstract][Full Text] [Related]
23. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures. Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095 [TBL] [Abstract][Full Text] [Related]
24. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. Amento EP; Kurnick JT; Krane SM J Immunol; 1985 Jan; 134(1):350-7. PubMed ID: 2578047 [TBL] [Abstract][Full Text] [Related]
25. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907 [TBL] [Abstract][Full Text] [Related]
26. T cell products activating stem cells: further studies on the origin and action of the factor(s). Cerny J; Waner EB; Rubin AS J Immunol; 1975 Aug; 115(2):513-8. PubMed ID: 1080170 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein. Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954 [TBL] [Abstract][Full Text] [Related]
28. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. Proust JJ; Buchholz MA; Nordin AA J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a lymphokine produced by human T cells which inhibits collagen synthesis. Rosenbloom J; McArthur W; Malamud D; Jimenez S Cell Immunol; 1983 Oct; 81(1):192-8. PubMed ID: 6604586 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a low molecular weight suppressor of lymphocyte proliferation from guinea pig L2C leukemia cells. Collins DP; Cook DJ; Ricardo MJ Cell Immunol; 1987 Apr; 105(2):397-410. PubMed ID: 3494530 [TBL] [Abstract][Full Text] [Related]
31. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines. Scott DW; O'Garra A; Warren D; Klaus GG J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976 [TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor. Benveniste EN; Merrill JE; Kaufman SE; Golde DW; Gasson JC Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3930-4. PubMed ID: 2987954 [TBL] [Abstract][Full Text] [Related]
33. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells. Clark-Lewis I; Kent SB; Schrader JW J Biol Chem; 1984 Jun; 259(12):7488-94. PubMed ID: 6429132 [TBL] [Abstract][Full Text] [Related]
34. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF). Pisko EJ; Foster SL; White RE; Panetti M; Turner RA J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423 [TBL] [Abstract][Full Text] [Related]
35. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes. Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146 [TBL] [Abstract][Full Text] [Related]
36. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells. Sherris D; Stohl W; Mayer L J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506 [TBL] [Abstract][Full Text] [Related]
37. T-derived colony-inhibiting activity: partial characterization and mechanism of action. Piaggio G; Bacigalupo A; Frassoni F; Podestà M; Repetto M; Risso A; Cosulich E; Marmont AM Acta Haematol; 1985; 74(4):195-9. PubMed ID: 3939059 [TBL] [Abstract][Full Text] [Related]
38. JM, a Thy-ALL cell line produces both inhibitory and stimulatory lymphokines for bone marrow progenitor cells. Michalevicz R; Taheri MR; Katz FE; Blacklock HA; Ivory KI; Hoffbrand VA Leuk Res; 1987; 11(7):649-54. PubMed ID: 3112472 [TBL] [Abstract][Full Text] [Related]
39. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor. Schreiber RD; Altman A; Katz DH J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288 [TBL] [Abstract][Full Text] [Related]
40. Leukemia derived growth factors produced by human malignant T-lymphoid cell lines. Uittenbogaart CH; Nishanian PG; Anisman DJ; Erikson TK; Fahey JL Cancer Res; 1986 Mar; 46(3):1219-23. PubMed ID: 3080240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]